DefiniGEN is a supplier of human liver and pancreatic cells for preclinical drug discovery and disease modelling using human Induced Pluripotent Stem Cells (hIPSC). The resulting products deliver major benefits for the pharmaceutical sector by providing human cells which can offer maximum predictivity of the efficacy and safety of compounds through the drug development process